Get started
Author

Sylvain Rault

Observed names: R A Marque Sylvain, RAULT S., RAULT, Sylvain, Rault S, Rault S., Rault, Sylvain, S RAULT, S Rault, S. RAULT, S. Rault, S. Rault,, SYLVAIN RAULT, Sylvain RAULT, Sylvain Rault,
Observed institutions: Université de Tours, University of Geneva, Centre National de la Recherche Scientifique, University of Salerno, Inserm, Universitat de València, Universidad de Salamanca, University of Ferrara, Aix-Marseille Université, Normandie Université, University Hospital of Geneva, Pitié-Salpêtrière Hospital, Servier (France), GREYC, Cyceron, Institut de Génomique Fonctionnelle, Centre d'Etudes et de Recherche sur le Médicament de Normandie, Neuropsychopharmacologie Moléculaire, Cellulaire et Fonctionnelle, University of Greenwich, Université de Rouen Normandie, University of Portsmouth, Assiut University, Université de Caen Normandie
OpenAlex ID: A5113468466
Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents
2017 · Marie Jouanne, Sylvain Rault, et al. · European Journal of Medicinal Chemistry · 254
Synthesis and antiplasmodial activity of new 4-aryl-2-trichloromethylquinazolines
2007 · Pierre Verhaeghe, Nadine Azas, et al. · Bioorganic & Medicinal Chemistry Letters · 166
New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives
2000 · Pascal Sonnet, Patrick Dallemagne, et al. · Bioorganic & Medicinal Chemistry · 126
Synthesis and Structure–Affinity Relationships of Selective High-Affinity 5-HT 4 Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers
2012 · Emmanuelle Dubost, Noé Dumas, et al. · Journal of Medicinal Chemistry · 101
Reactivity of 3-Iodoimidazo[1,2-a]pyridines Using a Suzuki-Type Cross-Coupling Reaction
2000 · Cécile Enguehard, Jean-Louis Renou, et al. · The Journal of Organic Chemistry · 97
Toward Safer Thrombolytic Agents in Stroke: Molecular Requirements for NMDA Receptor-Mediated Neurotoxicity
2008 · Jose P Lopez-Atalaya, Benoit D Roussel, et al. · Journal of Cerebral Blood Flow & Metabolism · 94
Synthesis of novel halopyridinylboronic acids and esters. Part 4: Halopyridin-2-yl-boronic acids and esters are stable, crystalline partners for classical Suzuki cross-coupling
2003 · Alexandre Bouillon, Jean-Charles Lancelot, et al. · Tetrahedron · 93
Synthesis of novel halopyridinylboronic acids and esters. Part 1: 6-Halopyridin-3-yl-boronic acids and esters
2002 · Alexandre Bouillon, Jean-Charles Lancelot, et al. · Tetrahedron · 88
Synthesis of new pyrrolo[1,2-a]quinoxalines: potential non-peptide glucagon receptor antagonists
1998 · Jean Guillon, Patrick Dallemagne, et al. · European Journal of Medicinal Chemistry · 88
Selective ortho-Bromination of Substituted Benzaldoximes Using Pd-Catalyzed C–H Activation: Application to the Synthesis of Substituted 2-Bromobenzaldehydes
2011 · Emmanuelle Dubost, Christine Fossey, et al. · The Journal of Organic Chemistry · 82
Effect of A-Ring Modifications on the DNA-Binding Behavior and Cytotoxicity of Pyrrolo[2,1-c][1,4]benzodiazepines
1999 · David E. Thurston, D. Subhas Bose, et al. · Journal of Medicinal Chemistry · 82
Suzuki-type cross-coupling reaction of 3-iodoindazoles with aryl boronic acids: A general and flexible route to 3-arylindazoles
1999 · Valérie Collot, Patrick Dallemagne, et al. · Tetrahedron · 82
Design, Synthesis, and Evaluation of Novel Thienopyrrolizinones as Antitubulin Agents
2004 · Vincent Lisowski, Stéphane Léonce, et al. · Journal of Medicinal Chemistry · 80
Nanocarriers for the targeted treatment of ovarian cancers
2012 · Julie Tomasina, Stéphanie Lheureux, et al. · Biomaterials · 78
Synthesis of novel halopyridinylboronic acids and esters. Part 2: 2,4, or 5-Halopyridin-3-yl-boronic acids and esters
2002 · Alexandre Bouillon, Jean-Charles Lancelot, et al. · Tetrahedron · 78
Use of allostery to identify inhibitors of calmodulin-induced activation of Bacillus anthracis edema factor
2010 · Elodie Laine, Christophe Goncalves, et al. · Proceedings of the National Academy of Sciences · 75
First Identification of Boronic Species as Novel Potential Inhibitors of the Staphylococcus aureus NorA Efflux Pump
2014 · Fanny Fontaine, Arnaud Hequet, et al. · Journal of Medicinal Chemistry · 73
Novel Selective and Partial Agonists of 5-HT3Receptors. Part 1. Synthesis and Biological Evaluation of Piperazinopyrrolothienopyrazines
1996 · Sylvain Rault, Jean-Charles Lancelot, et al. · Journal of Medicinal Chemistry · 72
Discovery of a new antileishmanial hit in 8-nitroquinoline series
2012 · Lucie Paloque, Pierre Verhaeghe, et al. · European Journal of Medicinal Chemistry · 67
Novel and Selective Partial Agonists of 5-HT3 Receptors. 2. Synthesis and Biological Evaluation of Piperazinopyridopyrrolopyrazines, Piperazinopyrroloquinoxalines, and Piperazinopyridopyrroloquinoxalines
1997 · Hervé Prunier, Sylvain Rault, et al. · Journal of Medicinal Chemistry · 65
Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents
2006 · C. Rochais, V. Lisowski, et al. · Bioorganic & Medicinal Chemistry · 64
Synthesis of novel halopyridinylboronic acids and esters. Part 3: 2, or 3-Halopyridin-4-yl-boronic acids and esters
2002 · Alexandre Bouillon, Jean-Charles Lancelot, et al. · Tetrahedron · 64
First combined selective N- and C-arylations with boronic acids: application to the synthesis of 1,3-diarylindazoles
2000 · Valérie Collot, Philippe R Bovy, et al. · Tetrahedron Letters · 62
Synthesis and in vitro antiplasmodial evaluation of 4-anilino-2-trichloromethylquinazolines
2009 · Pierre Verhaeghe, Nadine Azas, et al. · Bioorganic & Medicinal Chemistry · 61
Synthesis of bile acid derivatives and in vitro cytotoxic activity with pro-apoptotic process on multiple myeloma (KMS-11), glioblastoma multiforme (GBM), and colonic carcinoma (HCT-116) human cell lines
2010 · Dominique Brossard, Laïla El Kihel, et al. · European Journal of Medicinal Chemistry · 60
Works count: 682
Citation count: 7,801
H-index: 43
I10-index: 235
Year
Topic
Type